Flávia Leite Souza Santos

Suggest Changes
Learn More
The use of all trans-retinoic acid (ATRA) is the basis of treatment of acute promyelocytic leukemia (APL) and represents the paradigm of differentiation therapy. In general, ATRA is well-tolerated(More)
BACKGROUND Acute Promyelocytic Leukemia (APL) is characterized by its good response to treatment with all trans retinoic acid (ATRA). However, some patients receiving ATRA develop a serious(More)
Study carried out at Instituto Nacional de Câncer – Rio de Janeiro (RJ), Brazil. 1Instituto Nacional do Câncer – Rio de Janeiro (RJ), Brazil. 2Hemocentro de Ribeirão Preto – Ribeirão Preto (SP),(More)
  • 1